Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AA1 | P07900 | 1/20 | 1.00 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.75 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.75 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.75 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.75 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.75 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.75 |
| ▸ | FAAH | O00519 | 4/20 | 0.64 |
| ▸ | MEN1 | O00255 | 2/20 | 0.59 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.59 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.59 |
| ▸ | CES2 | O00748 | 3/20 | 0.56 |
| ▸ | CES1 | P23141 | 3/20 | 0.56 |
| ▸ | PPARG | P37231 | 4/20 | 0.54 |
| ▸ | PPARD | Q03181 | 4/20 | 0.54 |
| ▸ | PPARA | Q07869 | 4/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.54 |
| ▸ | GPR84 | Q9NQS5 | 3/20 | 0.54 |
| ▸ | HDAC11 | Q96DB2 | 3/20 | 0.54 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL572646 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL2403692 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL331039 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL4155670 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL7945790 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL23203038 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL5575814 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL20915286 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL20602650 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 | |
| SCHEMBL8977849 | 1.00 | HSP90AA1 (1.00) | HSP90AA1HDAC3HDAC1HDAC2HDAC8 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 120 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3350313-B1 | DERIVATION OF LIVER ORGANOIDS FROM HUMAN PLURIPOTENT STEM CELLS | AGENCY FOR SCIENCE TECH AND RESEARCH ASTARSTAR (SG) | 2025-11-26 | — | — | EP | claimed |
| US-20250297134-A1 | HIGH RATE BULK OXIDE CMP COMPOSITION | ENTEGRIS, INC. | 2025-09-25 | — | — | US | claimed |
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | INOLEX INVESTMENT CORPORATION (US) | 2025-09-16 | — | — | US | claimed |
| CN-110066281-B | Multi-target anti-tumor activity evodiamine derivative, and preparation method and application thereof | 中国人民解放军第二军医大学 | 2024-01-30 | — | — | CN | claimed |
| CN-116554079-B | Histone deacetylase inhibitor and application thereof | 南京市鸿舜医药科技有限公司 | 2023-11-10 | — | — | CN | claimed |
| EP-4240314-A1 | BIOBASED GLYCERYL HEPTANOATE ESTER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | Inolex Investment Corporation (US) | 2023-09-13 | — | — | EP | claimed |
| CN-116554079-A | Histone deacetylase inhibitor and application thereof | 南京市鸿舜医药科技有限公司 | 2023-08-08 | — | — | CN | claimed |
| CN-114105958-B | Hydroximic acid-containing 2-phenylamino pyrimidine derivatives and application thereof | 郑州大学第一附属医院 | 2022-11-22 | — | — | CN | claimed |
| CN-113387840-B | PD-1/PD-L1 and HDACs double-target inhibitor, preparation method and application | 中国药科大学 | 2022-11-08 | — | — | CN | claimed |
| CN-109879790-B | Amide micromolecule organic compound with indole or indole analogue as mother nucleus structure, application and preparation method thereof | 华东师范大学 | 2022-09-20 | — | — | CN | claimed |
| WO-2022098829-A1 | BIOBASED GLYCERYL HEPTANOATE ESTER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | INOLEX INVESTMENT CORPORATION (US) | 2022-05-12 | — | — | WO | claimed |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2022-05-10 | — | — | US | claimed |
| US-20220135769-A1 | BIOBASED GLYCERYL HEPTANOATE ESTER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | INOLEX INVESTMENT CORPORATION (US) | 2022-05-05 | — | — | US | claimed |
| CN-114105958-A | Hydroximic acid-containing 2-phenylamino pyrimidine derivatives and application thereof | 郑州大学第一附属医院 | 2022-03-01 | — | — | CN | claimed |
| CN-111632749-A | Beneficiation method for recovering copper oxide from copper oxide acid leaching residues | 西北矿冶研究院 | 2020-09-08 | — | — | CN | claimed |
| CN-111632746-A | Beneficiation method for improving copper recovery rate of copper oxide acid leaching residue | 西北矿冶研究院 | 2020-09-08 | — | — | CN | claimed |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | XIAMEN SINOPEG BIOTECH CO., LTD. (CN) | 2017-11-02 | — | — | US | claimed |
| CN-1028227-C | Pharmacologically active 1,5-diarly-3-substituted-pyrazoles and method for synthesizing the same | ORTHO PHARMA CORP (US) | 1995-04-19 | — | — | CN | claimed |
| CN-87103953-A | Pharmaceutically active 1, 5-diaryl-3-substituted pyrazoles and synthesis method thereof | — | 1987-12-09 | — | — | CN | claimed |
| US-4579844-A | APPLYING AN ARYLACETOHYDROXAMIC ACID DERIVATIVE | JOHNSON & JOHNSON (US) | 1986-04-01 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12415904-B2 | Biobased glyceryl heptanoate ester compositions and methods of making and using the same | SGMS1, MGLL, CCL11 | HSP90AA1 1742/4885HDAC3 3593/4885HDAC1 3853/4885 |
| US-20220135769-A1 | BIOBASED GLYCERYL HEPTANOATE ESTER COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME | SGMS1, MGLL, CCL11 | HSP90AA1 1742/4885HDAC3 3593/4885HDAC1 3853/4885 |
| US-11324827-B2 | Multifunctionalized polyethylene glycol derivative and preparation method therefor | HDGF, F11, F12 | HSP90AA1 3362/4885HDAC3 3798/4885HDAC1 1616/4885 |
| US-20170312363-A1 | MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR | HDGF, F11, F12 | HSP90AA1 3362/4885HDAC3 3798/4885HDAC1 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.